Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Sauer, Tim
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Beneyto-Calabuig S
,
Merbach AKathrin
,
Kniffka J-A
,
Antes M
,
Szu-Tu C
,
Rohde C
,
Waclawiczek A
,
Stelmach P
,
Gräßle S
,
Pervan P
, et al.
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.
Cell Stem Cell. 2023.
PubMed
Google Scholar
Waclawiczek A
,
Leppa A-M
,
Renders S
,
Stumpf K
,
Reyneri C
,
Betz B
,
Janssen M
,
Shahswar R
,
Donato E
,
Karpova D
, et al.
Combinatorial BCL-2 family expression in Acute Myeloid Leukemia Stem Cells predicts clinical response to Azacitidine/Venetoclax.
Cancer Discov. 2023.
PubMed
Google Scholar
E
Han H
,
Wang L
,
Ding Y
,
Neuber B
,
Hueckelhoven-Krauss AGabriele
,
Lin M
,
Yao H
,
Chen Q
,
Sauer T
,
Schubert M-L
, et al.
Extracorporeal photopheresis as a promising strategy for the treatment of GvHD after CAR-T cell therapy.
Blood Adv. 2024.
PubMed
Google Scholar
I
Enßle JC
,
Wolf S
,
Scheich S
,
Weber S
,
Kramer M
,
Ruhnke L
,
Schliemann C
,
Mikesch J-H
,
Krause S
,
Sauer T
, et al.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer. 2023.
PubMed
Google Scholar
Stelljes M
,
Raffel S
,
Alakel N
,
Wäsch R
,
Kondakci M
,
Scholl S
,
Rank A
,
Hänel M
,
Spriewald B
,
Hanoun M
, et al.
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
J Clin Oncol. 2023:JCO2300546.
PubMed
Google Scholar
Q
Jaramillo S
,
Le Cornet L
,
Kratzmann M
,
Krisam J
,
Görner M
,
Hänel M
,
Röllig C
,
Wass M
,
Scholl S
,
Ringhoffer M
, et al.
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
Trials. 2023;24(1):591.
PubMed
Google Scholar
R
Mathioudaki A
,
Wang X
,
Sedloev DNikolov
,
Huth R
,
Kamal A
,
Hundemer M
,
Liu Y
,
Vasileiou S
,
Lulla PD
,
Müller-Tidow C
, et al.
The remission status of AML patients post alloSCT is associated with a distinct single-cell bone marrow T cell signature.
Blood. 2024.
PubMed
Google Scholar
T
Schubert M-L
,
Schmitt A
,
Hückelhoven-Krauss A
,
Neuber B
,
Kunz A
,
Waldhoff P
,
Vonficht D
,
Yousefian S
,
Jopp-Saile L
,
Wang L
, et al.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
J Hematol Oncol. 2023;16(1):79.
PubMed
Google Scholar